Differentiation of post streptococcal reactive arthritis from acute rheumatic fever
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1546-0096
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Differentiation of post streptococcal reactive arthritis from acute rheumatic fever ; volume:6 ; number:1 ; day:15 ; month:9 ; year:2008 ; pages:1 ; date:9.2008
Pediatric rheumatology ; 6, Heft 1 (15.9.2008), 1, 9.2008
- Urheber
-
Barash, J.
Mashihach, E.
Navon-Elkan, P.
Berkun, Y.
Harel, L.
Tauber, T.
Padeh, S.
Hashkes, PJ
Uziel, Y.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1546-0096-6-S1-P198
- URN
-
urn:nbn:de:101:1-2019111722261407376449
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Barash, J.
- Mashihach, E.
- Navon-Elkan, P.
- Berkun, Y.
- Harel, L.
- Tauber, T.
- Padeh, S.
- Hashkes, PJ
- Uziel, Y.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Post-streptococcal reactive arthritis in children: a distinct entity from acute rheumatic fever
The effect of group A streptococcal carrier on the epidemic model of acute rheumatic fever
Pathology and therapy of rheumatic fever
Understanding group A streptococcal pharyngitis and skin infections as causes of rheumatic fever: protocol for a prospective disease incidence study
Immunopathology of rheumatic fever and rheumatoid arthritis
Cardiac magnetic resonance in acute rheumatic fever
Prophylaxis of Rheumatic Fever/Rheumatic Heart Disease–Penicillin or Azithromycin, Who Wins?
Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations
A community-based program to reduce acute rheumatic fever and rheumatic heart disease in northern Australia
Secondary prophylaxis in rheumatic fever: is it time to change?
Sharing success – understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease
MBL2 gene polymorphism rs1800450 and rheumatic fever with and without rheumatic heart disease: an Egyptian pilot study
Post-streptococcal reactive arthritis in children: a distinct entity from acute rheumatic fever
The effect of group A streptococcal carrier on the epidemic model of acute rheumatic fever
Pathology and therapy of rheumatic fever
Understanding group A streptococcal pharyngitis and skin infections as causes of rheumatic fever: protocol for a prospective disease incidence study
Immunopathology of rheumatic fever and rheumatoid arthritis
Cardiac magnetic resonance in acute rheumatic fever
Prophylaxis of Rheumatic Fever/Rheumatic Heart Disease–Penicillin or Azithromycin, Who Wins?
Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations
A community-based program to reduce acute rheumatic fever and rheumatic heart disease in northern Australia
Secondary prophylaxis in rheumatic fever: is it time to change?
Sharing success – understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease
MBL2 gene polymorphism rs1800450 and rheumatic fever with and without rheumatic heart disease: an Egyptian pilot study
Post-streptococcal reactive arthritis in children: a distinct entity from acute rheumatic fever
The effect of group A streptococcal carrier on the epidemic model of acute rheumatic fever
Pathology and therapy of rheumatic fever
Understanding group A streptococcal pharyngitis and skin infections as causes of rheumatic fever: protocol for a prospective disease incidence study
Immunopathology of rheumatic fever and rheumatoid arthritis
Cardiac magnetic resonance in acute rheumatic fever
Prophylaxis of Rheumatic Fever/Rheumatic Heart Disease–Penicillin or Azithromycin, Who Wins?
Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations
A community-based program to reduce acute rheumatic fever and rheumatic heart disease in northern Australia
Secondary prophylaxis in rheumatic fever: is it time to change?
Sharing success – understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease